Alexandria Real Estate Equities Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在住宅與商業類房地產信託基金(REIT)行業排名73/196位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價68.85。中期看,股價處於下降通道。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Alexandria Real Estate Equities Inc評分
相關信息
行業排名
73 / 196
全市場排名
151 / 4582
所屬行業
住宅與商業類房地產信託基金(REIT)
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
15
分析師
持有
評級
68.846
目標均價
+53.09%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Alexandria Real Estate Equities Inc亮點
亮點風險
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.
公司代碼ARE
公司Alexandria Real Estate Equities Inc
CEOMoglia (Peter M)
網址https://www.are.com/
常見問題
Alexandria Real Estate Equities Inc(ARE)的當前股價是多少?
Alexandria Real Estate Equities Inc(ARE)的當前股價是 47.960。
Alexandria Real Estate Equities Inc 的股票代碼是什麼?
Alexandria Real Estate Equities Inc的股票代碼是ARE。
Alexandria Real Estate Equities Inc股票的52週最高點是多少?
Alexandria Real Estate Equities Inc股票的52週最高點是105.140。
Alexandria Real Estate Equities Inc股票的52週最低點是多少?
Alexandria Real Estate Equities Inc股票的52週最低點是44.103。
Alexandria Real Estate Equities Inc的市值是多少?
Alexandria Real Estate Equities Inc的市值是8.17B。
Alexandria Real Estate Equities Inc的淨利潤是多少?
Alexandria Real Estate Equities Inc的淨利潤為309.56M。
現在Alexandria Real Estate Equities Inc(ARE)的股票是買入、持有還是賣出?
根據分析師評級,Alexandria Real Estate Equities Inc(ARE)的總體評級為持有,目標價格為68.846。
Alexandria Real Estate Equities Inc(ARE)股票的每股收益(EPS TTM)是多少
Alexandria Real Estate Equities Inc(ARE)股票的每股收益(EPS TTM)是-2.470。